I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 6 studies | 21% ± 4% | |
| natural killer cell | 5 studies | 25% ± 9% | |
| plasmablast | 4 studies | 30% ± 14% | |
| CD4-positive, alpha-beta T cell | 4 studies | 22% ± 6% | |
| epithelial cell | 4 studies | 21% ± 6% | |
| pro-B cell | 4 studies | 24% ± 5% | |
| dendritic cell | 4 studies | 17% ± 2% | |
| CD8-positive, alpha-beta T cell | 4 studies | 25% ± 5% | |
| B cell | 3 studies | 18% ± 2% | |
| hematopoietic precursor cell | 3 studies | 25% ± 7% | |
| abnormal cell | 3 studies | 28% ± 17% | |
| lymphocyte | 3 studies | 20% ± 4% | |
| GABAergic neuron | 3 studies | 37% ± 5% | |
| glutamatergic neuron | 3 studies | 48% ± 2% | |
| neural progenitor cell | 3 studies | 21% ± 2% | |
| megakaryocyte-erythroid progenitor cell | 3 studies | 22% ± 1% | |
| transit amplifying cell | 3 studies | 49% ± 27% | |
| astrocyte | 3 studies | 31% ± 8% | |
| cardiac muscle cell | 3 studies | 23% ± 4% | |
| effector CD8-positive, alpha-beta T cell | 3 studies | 22% ± 2% | |
| T cell | 3 studies | 20% ± 2% |
